Found 93 hits of Enzyme Inhibition Constant Data Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Melanin-concentrating hormone receptor 1
(Homo sapiens (Human)) | BDBM50297624
(1-phenyl-N-(1-((1-(4-(trifluoromethyl)phenyl)-1H-p...)Show SMILES FC(F)(F)c1ccc(cc1)-n1ccc(CN2CCC(CC2)NC(=O)N2CCn3cccc3C2c2ccccc2)c1 Show InChI InChI=1S/C31H32F3N5O/c32-31(33,34)25-8-10-27(11-9-25)38-18-12-23(22-38)21-36-16-13-26(14-17-36)35-30(40)39-20-19-37-15-4-7-28(37)29(39)24-5-2-1-3-6-24/h1-12,15,18,22,26,29H,13-14,16-17,19-21H2,(H,35,40) | Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Displacement of [125I]MCH from human MCH1 receptor expressed in HEK293 cells |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Melanin-concentrating hormone receptor 1
(Homo sapiens (Human)) | BDBM50297625
(1-(2-(3,5-dimethyl-1H-pyrazol-1-yl)-1-phenylethyl)...)Show SMILES Cc1cc(C)n(CC(NC(=O)NC2CCN(Cc3ccn(c3)-c3ccc(cc3)C(F)(F)F)CC2)c2ccccc2)n1 Show InChI InChI=1S/C31H35F3N6O/c1-22-18-23(2)40(37-22)21-29(25-6-4-3-5-7-25)36-30(41)35-27-13-15-38(16-14-27)19-24-12-17-39(20-24)28-10-8-26(9-11-28)31(32,33)34/h3-12,17-18,20,27,29H,13-16,19,21H2,1-2H3,(H2,35,36,41) | Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Displacement of [125I]MCH from human MCH1 receptor expressed in HEK293 cells |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Melanin-concentrating hormone receptor 1
(Homo sapiens (Human)) | BDBM50297626
(2-(4-fluorophenyl)-N-(1-((1-(4-(trifluoromethyl)ph...)Show SMILES Fc1ccc(cc1)C1CCCN1C(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1 Show InChI InChI=1S/C28H30F4N4O/c29-23-7-3-21(4-8-23)26-2-1-14-36(26)27(37)33-24-12-15-34(16-13-24)18-20-11-17-35(19-20)25-9-5-22(6-10-25)28(30,31)32/h3-11,17,19,24,26H,1-2,12-16,18H2,(H,33,37) | Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Displacement of [125I]MCH from human MCH1 receptor expressed in HEK293 cells |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Melanin-concentrating hormone receptor 1
(Homo sapiens (Human)) | BDBM50297627
(1-(1-phenyl-2-(pyrazin-2-yl)ethyl)-3-(1-((1-(4-(tr...)Show SMILES FC(F)(F)c1ccc(cc1)-n1ccc(CN2CCC(CC2)NC(=O)NC(Cc2cnccn2)c2ccccc2)c1 Show InChI InChI=1S/C30H31F3N6O/c31-30(32,33)24-6-8-27(9-7-24)39-17-10-22(21-39)20-38-15-11-25(12-16-38)36-29(40)37-28(23-4-2-1-3-5-23)18-26-19-34-13-14-35-26/h1-10,13-14,17,19,21,25,28H,11-12,15-16,18,20H2,(H2,36,37,40) | Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 17 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Displacement of [125I]MCH from human MCH1 receptor expressed in HEK293 cells |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Melanin-concentrating hormone receptor 1
(Homo sapiens (Human)) | BDBM50297628
(1-(1-phenyl-2-(1H-pyrazol-1-yl)ethyl)-3-(1-((1-(4-...)Show SMILES FC(F)(F)c1ccc(cc1)-n1ccc(CN2CCC(CC2)NC(=O)NC(Cn2cccn2)c2ccccc2)c1 Show InChI InChI=1S/C29H31F3N6O/c30-29(31,32)24-7-9-26(10-8-24)37-18-11-22(20-37)19-36-16-12-25(13-17-36)34-28(39)35-27(21-38-15-4-14-33-38)23-5-2-1-3-6-23/h1-11,14-15,18,20,25,27H,12-13,16-17,19,21H2,(H2,34,35,39) | Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 19 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Displacement of [125I]MCH from human MCH1 receptor expressed in HEK293 cells |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Melanin-concentrating hormone receptor 1
(Homo sapiens (Human)) | BDBM50297629
(2-(pyridin-3-yl)-N-(1-((1-(4-(trifluoromethyl)phen...)Show SMILES FC(F)(F)c1ccc(cc1)-n1ccc(CN2CCC(CC2)NC(=O)N2CCCC2c2cccnc2)c1 Show InChI InChI=1S/C27H30F3N5O/c28-27(29,30)22-5-7-24(8-6-22)34-16-9-20(19-34)18-33-14-10-23(11-15-33)32-26(36)35-13-2-4-25(35)21-3-1-12-31-17-21/h1,3,5-9,12,16-17,19,23,25H,2,4,10-11,13-15,18H2,(H,32,36) | Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 21 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Displacement of [125I]MCH from human MCH1 receptor expressed in HEK293 cells |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Melanin-concentrating hormone receptor 1
(Homo sapiens (Human)) | BDBM50297630
(3-(hydroxymethyl)-N-(1-((1-(4-(trifluoromethyl)phe...)Show SMILES OCC1CCCN(C1)C(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1 Show InChI InChI=1S/C24H31F3N4O2/c25-24(26,27)20-3-5-22(6-4-20)30-13-7-18(15-30)14-29-11-8-21(9-12-29)28-23(33)31-10-1-2-19(16-31)17-32/h3-7,13,15,19,21,32H,1-2,8-12,14,16-17H2,(H,28,33) | Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 23 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Displacement of [125I]MCH from human MCH1 receptor expressed in HEK293 cells |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Melanin-concentrating hormone receptor 1
(Homo sapiens (Human)) | BDBM50297621
(1-(2-(1H-imidazol-1-yl)-1-phenylethyl)-3-(1-((1-(4...)Show SMILES FC(F)(F)c1ccc(cc1)-n1ccc(CN2CCC(CC2)NC(=O)NC(Cn2ccnc2)c2ccccc2)c1 Show InChI InChI=1S/C29H31F3N6O/c30-29(31,32)24-6-8-26(9-7-24)38-16-10-22(19-38)18-36-14-11-25(12-15-36)34-28(39)35-27(20-37-17-13-33-21-37)23-4-2-1-3-5-23/h1-10,13,16-17,19,21,25,27H,11-12,14-15,18,20H2,(H2,34,35,39) | Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 25 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Displacement of [125I]MCH from human MCH1 receptor expressed in HEK293 cells |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Melanin-concentrating hormone receptor 1
(Homo sapiens (Human)) | BDBM50297631
(2-(pyridin-3-ylmethyl)-N-(1-((1-(4-(trifluoromethy...)Show SMILES FC(F)(F)c1ccc(cc1)-n1ccc(CN2CCC(CC2)NC(=O)N2CCCC2Cc2cccnc2)c1 Show InChI InChI=1S/C28H32F3N5O/c29-28(30,31)23-5-7-25(8-6-23)35-16-9-22(20-35)19-34-14-10-24(11-15-34)33-27(37)36-13-2-4-26(36)17-21-3-1-12-32-18-21/h1,3,5-9,12,16,18,20,24,26H,2,4,10-11,13-15,17,19H2,(H,33,37) | Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 26 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Displacement of [125I]MCH from human MCH1 receptor expressed in HEK293 cells |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Melanin-concentrating hormone receptor 1
(Homo sapiens (Human)) | BDBM50297632
(1-((1H-imidazol-2-yl)(phenyl)methyl)-3-(1-((1-(4-(...)Show SMILES FC(F)(F)c1ccc(cc1)-n1ccc(CN2CCC(CC2)NC(=O)NC(c2ncc[nH]2)c2ccccc2)c1 Show InChI InChI=1S/C28H29F3N6O/c29-28(30,31)22-6-8-24(9-7-22)37-17-10-20(19-37)18-36-15-11-23(12-16-36)34-27(38)35-25(26-32-13-14-33-26)21-4-2-1-3-5-21/h1-10,13-14,17,19,23,25H,11-12,15-16,18H2,(H,32,33)(H2,34,35,38) | Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 27 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Displacement of [125I]MCH from human MCH1 receptor expressed in HEK293 cells |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Melanin-concentrating hormone receptor 1
(Homo sapiens (Human)) | BDBM50297633
(4-methyl-2-phenyl-N-(1-((1-(4-(trifluoromethyl)phe...)Show SMILES CN1CCN(C(C1)c1ccccc1)C(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1 Show InChI InChI=1S/C29H34F3N5O/c1-34-17-18-37(27(21-34)23-5-3-2-4-6-23)28(38)33-25-12-14-35(15-13-25)19-22-11-16-36(20-22)26-9-7-24(8-10-26)29(30,31)32/h2-11,16,20,25,27H,12-15,17-19,21H2,1H3,(H,33,38) | Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 28 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Displacement of [125I]MCH from human MCH1 receptor expressed in HEK293 cells |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Melanin-concentrating hormone receptor 1
(Homo sapiens (Human)) | BDBM50245454
(2-(3-chlorophenoxy)-N-(1-((1-(4-(trifluoromethyl)p...)Show SMILES FC(F)(F)c1ccc(cc1)-n1ccc(CN2CCC(CC2)NC(=O)COc2cccc(Cl)c2)c1 Show InChI InChI=1S/C25H25ClF3N3O2/c26-20-2-1-3-23(14-20)34-17-24(33)30-21-9-11-31(12-10-21)15-18-8-13-32(16-18)22-6-4-19(5-7-22)25(27,28)29/h1-8,13-14,16,21H,9-12,15,17H2,(H,30,33) | Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 29 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Displacement of [125I]MCH from human MCH1 receptor expressed in HEK293 cells |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Melanin-concentrating hormone receptor 1
(Homo sapiens (Human)) | BDBM50297634
((S)-1-(2-hydroxy-1-phenylethyl)-3-(1-((1-(4-(trifl...)Show SMILES OC[C@@H](NC(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1)c1ccccc1 |r| Show InChI InChI=1S/C26H29F3N4O2/c27-26(28,29)21-6-8-23(9-7-21)33-15-10-19(17-33)16-32-13-11-22(12-14-32)30-25(35)31-24(18-34)20-4-2-1-3-5-20/h1-10,15,17,22,24,34H,11-14,16,18H2,(H2,30,31,35)/t24-/m1/s1 | Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Displacement of [125I]MCH from human MCH1 receptor expressed in HEK293 cells |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Melanin-concentrating hormone receptor 1
(Homo sapiens (Human)) | BDBM50297635
(4-(2-hydroxyphenyl)-N-(1-((1-(4-(trifluoromethyl)p...)Show SMILES Oc1ccccc1C1CCN(CC1)C(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1 Show InChI InChI=1S/C29H33F3N4O2/c30-29(31,32)23-5-7-25(8-6-23)36-16-9-21(20-36)19-34-14-12-24(13-15-34)33-28(38)35-17-10-22(11-18-35)26-3-1-2-4-27(26)37/h1-9,16,20,22,24,37H,10-15,17-19H2,(H,33,38) | Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 36 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Displacement of [125I]MCH from human MCH1 receptor expressed in HEK293 cells |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Melanin-concentrating hormone receptor 1
(Homo sapiens (Human)) | BDBM50297620
(1-(1-phenyl-2-(1H-1,2,4-triazol-1-yl)ethyl)-3-(1-(...)Show SMILES FC(F)(F)c1ccc(cc1)-n1ccc(CN2CCC(CC2)NC(=O)NC(Cn2cncn2)c2ccccc2)c1 Show InChI InChI=1S/C28H30F3N7O/c29-28(30,31)23-6-8-25(9-7-23)37-15-10-21(17-37)16-36-13-11-24(12-14-36)34-27(39)35-26(18-38-20-32-19-33-38)22-4-2-1-3-5-22/h1-10,15,17,19-20,24,26H,11-14,16,18H2,(H2,34,35,39) | Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 38 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Displacement of [125I]MCH from human MCH1 receptor expressed in HEK293 cells |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Melanin-concentrating hormone receptor 1
(Homo sapiens (Human)) | BDBM50297637
(2-(2-hydroxyethyl)-N-(1-((1-(4-(trifluoromethyl)ph...)Show SMILES OCCC1CCCCN1C(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1 Show InChI InChI=1S/C25H33F3N4O2/c26-25(27,28)20-4-6-22(7-5-20)31-15-8-19(18-31)17-30-13-9-21(10-14-30)29-24(34)32-12-2-1-3-23(32)11-16-33/h4-8,15,18,21,23,33H,1-3,9-14,16-17H2,(H,29,34) | Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 39 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Displacement of [125I]MCH from human MCH1 receptor expressed in HEK293 cells |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Melanin-concentrating hormone receptor 1
(Homo sapiens (Human)) | BDBM50297636
(1-(3-fluorobenzyl)-3-(1-((1-(4-(trifluoromethyl)ph...)Show SMILES Fc1cccc(CNC(=O)NC2CCN(Cc3ccn(c3)-c3ccc(cc3)C(F)(F)F)CC2)c1 Show InChI InChI=1S/C25H26F4N4O/c26-21-3-1-2-18(14-21)15-30-24(34)31-22-9-11-32(12-10-22)16-19-8-13-33(17-19)23-6-4-20(5-7-23)25(27,28)29/h1-8,13-14,17,22H,9-12,15-16H2,(H2,30,31,34) | Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 39 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Displacement of [125I]MCH from human MCH1 receptor expressed in HEK293 cells |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50297621
(1-(2-(1H-imidazol-1-yl)-1-phenylethyl)-3-(1-((1-(4...)Show SMILES FC(F)(F)c1ccc(cc1)-n1ccc(CN2CCC(CC2)NC(=O)NC(Cn2ccnc2)c2ccccc2)c1 Show InChI InChI=1S/C29H31F3N6O/c30-29(31,32)24-6-8-26(9-7-24)38-16-10-22(19-38)18-36-14-11-25(12-15-36)34-28(39)35-27(20-37-17-13-33-21-37)23-4-2-1-3-5-23/h1-10,13,16-17,19,21,25,27H,11-12,14-15,18,20H2,(H2,34,35,39) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 40 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human recombinant CYP3A4 after 45 mins |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Melanin-concentrating hormone receptor 1
(Homo sapiens (Human)) | BDBM50297638
(3-(pyrrolidine-1-carbonyl)-N-(1-((1-(4-(trifluorom...)Show SMILES FC(F)(F)c1ccc(cc1)-n1ccc(CN2CCC(CC2)NC(=O)N2CCCC(C2)C(=O)N2CCCC2)c1 Show InChI InChI=1S/C28H36F3N5O2/c29-28(30,31)23-5-7-25(8-6-23)35-17-9-21(19-35)18-33-15-10-24(11-16-33)32-27(38)36-14-3-4-22(20-36)26(37)34-12-1-2-13-34/h5-9,17,19,22,24H,1-4,10-16,18,20H2,(H,32,38) | Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 40 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Displacement of [125I]MCH from human MCH1 receptor expressed in HEK293 cells |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Melanin-concentrating hormone receptor 1
(Homo sapiens (Human)) | BDBM50297617
(1-((1-hydroxycyclohexyl)methyl)-3-(1-((1-(4-(trifl...)Show SMILES OC1(CNC(=O)NC2CCN(Cc3ccn(c3)-c3ccc(cc3)C(F)(F)F)CC2)CCCCC1 Show InChI InChI=1S/C25H33F3N4O2/c26-25(27,28)20-4-6-22(7-5-20)32-15-8-19(17-32)16-31-13-9-21(10-14-31)30-23(33)29-18-24(34)11-2-1-3-12-24/h4-8,15,17,21,34H,1-3,9-14,16,18H2,(H2,29,30,33) | Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 44 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Displacement of [125I]MCH from human MCH1 receptor expressed in HEK293 cells |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Melanin-concentrating hormone receptor 1
(Homo sapiens (Human)) | BDBM50297646
(1-(((1S,2R)-2-hydroxycyclohexyl)methyl)-3-(1-((1-(...)Show SMILES O[C@@H]1CCCC[C@H]1CNC(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1 |r| Show InChI InChI=1S/C25H33F3N4O2/c26-25(27,28)20-5-7-22(8-6-20)32-14-9-18(17-32)16-31-12-10-21(11-13-31)30-24(34)29-15-19-3-1-2-4-23(19)33/h5-9,14,17,19,21,23,33H,1-4,10-13,15-16H2,(H2,29,30,34)/t19-,23+/m0/s1 | Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 46 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Displacement of [125I]MCH from human MCH1 receptor expressed in HEK293 cells |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Melanin-concentrating hormone receptor 1
(Homo sapiens (Human)) | BDBM50297639
(3-(4-methoxyphenoxy)-N-(1-((1-(4-(trifluoromethyl)...)Show SMILES COc1ccc(OC2CN(C2)C(=O)NC2CCN(Cc3ccn(c3)-c3ccc(cc3)C(F)(F)F)CC2)cc1 Show InChI InChI=1S/C28H31F3N4O3/c1-37-24-6-8-25(9-7-24)38-26-18-35(19-26)27(36)32-22-11-13-33(14-12-22)16-20-10-15-34(17-20)23-4-2-21(3-5-23)28(29,30)31/h2-10,15,17,22,26H,11-14,16,18-19H2,1H3,(H,32,36) | Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 49 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Displacement of [125I]MCH from human MCH1 receptor expressed in HEK293 cells |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Melanin-concentrating hormone receptor 1
(Homo sapiens (Human)) | BDBM50297640
(1-((1-hydroxycyclohexyl)methyl)-1-methyl-3-(1-((1-...)Show SMILES CN(CC1(O)CCCCC1)C(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1 Show InChI InChI=1S/C26H35F3N4O2/c1-31(19-25(35)12-3-2-4-13-25)24(34)30-22-10-14-32(15-11-22)17-20-9-16-33(18-20)23-7-5-21(6-8-23)26(27,28)29/h5-9,16,18,22,35H,2-4,10-15,17,19H2,1H3,(H,30,34) | Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 57 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Displacement of [125I]MCH from human MCH1 receptor expressed in HEK293 cells |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Melanin-concentrating hormone receptor 1
(Homo sapiens (Human)) | BDBM50297644
(1-(((1R,2R)-2-hydroxycyclohexyl)methyl)-3-(1-((1-(...)Show SMILES O[C@@H]1CCCC[C@@H]1CNC(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1 |r| Show InChI InChI=1S/C25H33F3N4O2/c26-25(27,28)20-5-7-22(8-6-20)32-14-9-18(17-32)16-31-12-10-21(11-13-31)30-24(34)29-15-19-3-1-2-4-23(19)33/h5-9,14,17,19,21,23,33H,1-4,10-13,15-16H2,(H2,29,30,34)/t19-,23-/m1/s1 | Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 63 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Displacement of [125I]MCH from human MCH1 receptor expressed in HEK293 cells |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Melanin-concentrating hormone receptor 1
(Homo sapiens (Human)) | BDBM50297647
(4-benzyl-4-hydroxy-N-(1-((1-(4-(trifluoromethyl)ph...)Show SMILES OC1(Cc2ccccc2)CCN(CC1)C(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1 Show InChI InChI=1S/C30H35F3N4O2/c31-30(32,33)25-6-8-27(9-7-25)37-17-10-24(22-37)21-35-15-11-26(12-16-35)34-28(38)36-18-13-29(39,14-19-36)20-23-4-2-1-3-5-23/h1-10,17,22,26,39H,11-16,18-21H2,(H,34,38) | Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 63 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Displacement of [125I]MCH from human MCH1 receptor expressed in HEK293 cells |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Melanin-concentrating hormone receptor 1
(Homo sapiens (Human)) | BDBM50297645
(1-(2-morpholino-1-phenylethyl)-3-(1-((1-(4-(triflu...)Show SMILES FC(F)(F)c1ccc(cc1)-n1ccc(CN2CCC(CC2)NC(=O)NC(CN2CCOCC2)c2ccccc2)c1 Show InChI InChI=1S/C30H36F3N5O2/c31-30(32,33)25-6-8-27(9-7-25)38-15-10-23(21-38)20-36-13-11-26(12-14-36)34-29(39)35-28(24-4-2-1-3-5-24)22-37-16-18-40-19-17-37/h1-10,15,21,26,28H,11-14,16-20,22H2,(H2,34,35,39) | Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 66 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Displacement of [125I]MCH from human MCH1 receptor expressed in HEK293 cells |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Melanin-concentrating hormone receptor 1
(Homo sapiens (Human)) | BDBM50297619
(1-(2-(2-methyl-1H-imidazol-1-yl)-1-phenylethyl)-3-...)Show SMILES Cc1nccn1CC(NC(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1)c1ccccc1 Show InChI InChI=1S/C30H33F3N6O/c1-22-34-14-18-38(22)21-28(24-5-3-2-4-6-24)36-29(40)35-26-12-15-37(16-13-26)19-23-11-17-39(20-23)27-9-7-25(8-10-27)30(31,32)33/h2-11,14,17-18,20,26,28H,12-13,15-16,19,21H2,1H3,(H2,35,36,40) | Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 74 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Displacement of [125I]MCH from human MCH1 receptor expressed in HEK293 cells |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Melanin-concentrating hormone receptor 1
(Homo sapiens (Human)) | BDBM50297643
(CHEMBL550535 | N-(1-((1-(4-(trifluoromethyl)phenyl...)Show SMILES FC(F)(F)C1CCN(CC1)C1CN(C1)C(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1 Show InChI InChI=1S/C27H33F6N5O/c28-26(29,30)20-1-3-23(4-2-20)37-12-5-19(16-37)15-35-10-8-22(9-11-35)34-25(39)38-17-24(18-38)36-13-6-21(7-14-36)27(31,32)33/h1-5,12,16,21-22,24H,6-11,13-15,17-18H2,(H,34,39) | Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 81.8 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Displacement of [125I]MCH from human MCH1 receptor expressed in HEK293 cells |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Melanin-concentrating hormone receptor 1
(Homo sapiens (Human)) | BDBM50297618
(1-(3-Hydroxy-adamantan-1-yl)-3-{1-[1-(4-trifluorom...)Show SMILES OC12CC3CC(C1)CC(C3)(C2)NC(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1 |TLB:11:8:4:2.1.6,9:8:4.3.2:6,0:1:4:7.9.8,THB:9:3:6:7.8.10,10:8:4:2.1.6,10:1:4:7.9.8| Show InChI InChI=1S/C28H35F3N4O2/c29-28(30,31)22-1-3-24(4-2-22)35-10-5-19(17-35)16-34-8-6-23(7-9-34)32-25(36)33-26-12-20-11-21(13-26)15-27(37,14-20)18-26/h1-5,10,17,20-21,23,37H,6-9,11-16,18H2,(H2,32,33,36) | Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 82 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Displacement of [125I]MCH from human MCH1 receptor expressed in HEK293 cells |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Melanin-concentrating hormone receptor 1
(Homo sapiens (Human)) | BDBM50297648
(1-((1H-benzo[d]imidazol-2-yl)methyl)-3-(1-((1-(4-(...)Show SMILES FC(F)(F)c1ccc(cc1)-n1ccc(CN2CCC(CC2)NC(=O)NCc2nc3ccccc3[nH]2)c1 Show InChI InChI=1S/C26H27F3N6O/c27-26(28,29)19-5-7-21(8-6-19)35-14-9-18(17-35)16-34-12-10-20(11-13-34)31-25(36)30-15-24-32-22-3-1-2-4-23(22)33-24/h1-9,14,17,20H,10-13,15-16H2,(H,32,33)(H2,30,31,36) | Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 90 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Displacement of [125I]MCH from human MCH1 receptor expressed in HEK293 cells |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Melanin-concentrating hormone receptor 1
(Homo sapiens (Human)) | BDBM50297653
(3-(1,1-Dioxo-1lambda6-thiomorpholin-4-yl)-azetidin...)Show SMILES FC(F)(F)c1ccc(cc1)-n1ccc(CN2CCC(CC2)NC(=O)N2CC(C2)N2CCS(=O)(=O)CC2)c1 Show InChI InChI=1S/C25H32F3N5O3S/c26-25(27,28)20-1-3-22(4-2-20)32-10-5-19(16-32)15-30-8-6-21(7-9-30)29-24(34)33-17-23(18-33)31-11-13-37(35,36)14-12-31/h1-5,10,16,21,23H,6-9,11-15,17-18H2,(H,29,34) | Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 99 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Displacement of [125I]MCH from human MCH1 receptor expressed in HEK293 cells |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Melanin-concentrating hormone receptor 1
(Homo sapiens (Human)) | BDBM50297642
(1-(4-chloro-2-(hydroxymethyl)phenyl)-3-(1-((1-(4-(...)Show SMILES OCc1cc(Cl)ccc1NC(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1 Show InChI InChI=1S/C25H26ClF3N4O2/c26-20-3-6-23(18(13-20)16-34)31-24(35)30-21-8-10-32(11-9-21)14-17-7-12-33(15-17)22-4-1-19(2-5-22)25(27,28)29/h1-7,12-13,15,21,34H,8-11,14,16H2,(H2,30,31,35) | Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 111 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Displacement of [125I]MCH from human MCH1 receptor expressed in HEK293 cells |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Melanin-concentrating hormone receptor 1
(Homo sapiens (Human)) | BDBM50297650
(1-(1-(1H-imidazol-1-yl)-3-methylbutan-2-yl)-3-(1-(...)Show SMILES CC(C)C(Cn1ccnc1)NC(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1 Show InChI InChI=1S/C26H33F3N6O/c1-19(2)24(17-34-14-10-30-18-34)32-25(36)31-22-8-11-33(12-9-22)15-20-7-13-35(16-20)23-5-3-21(4-6-23)26(27,28)29/h3-7,10,13-14,16,18-19,22,24H,8-9,11-12,15,17H2,1-2H3,(H2,31,32,36) | Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 112 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Displacement of [125I]MCH from human MCH1 receptor expressed in HEK293 cells |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Melanin-concentrating hormone receptor 1
(Homo sapiens (Human)) | BDBM50297654
(3-acetamido-N-(1-((1-(4-(trifluoromethyl)phenyl)-1...)Show SMILES CC(=O)NC1CCN(C1)C(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1 Show InChI InChI=1S/C24H30F3N5O2/c1-17(33)28-21-9-13-32(16-21)23(34)29-20-7-10-30(11-8-20)14-18-6-12-31(15-18)22-4-2-19(3-5-22)24(25,26)27/h2-6,12,15,20-21H,7-11,13-14,16H2,1H3,(H,28,33)(H,29,34) | Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 120 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Displacement of [125I]MCH from human MCH1 receptor expressed in HEK293 cells |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Melanin-concentrating hormone receptor 1
(Homo sapiens (Human)) | BDBM50297616
((S)-3-hydroxy-N-(1-((1-(4-(trifluoromethyl)phenyl)...)Show SMILES O[C@H]1CCN(C1)C(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1 |r| Show InChI InChI=1S/C22H27F3N4O2/c23-22(24,25)17-1-3-19(4-2-17)28-11-5-16(14-28)13-27-9-6-18(7-10-27)26-21(31)29-12-8-20(30)15-29/h1-5,11,14,18,20,30H,6-10,12-13,15H2,(H,26,31)/t20-/m0/s1 | Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Displacement of [125I]MCH from human MCH1 receptor expressed in HEK293 cells |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Melanin-concentrating hormone receptor 1
(Homo sapiens (Human)) | BDBM50297615
((R)-3-hydroxy-N-(1-((1-(4-(trifluoromethyl)phenyl)...)Show SMILES O[C@@H]1CCN(C1)C(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1 |r| Show InChI InChI=1S/C22H27F3N4O2/c23-22(24,25)17-1-3-19(4-2-17)28-11-5-16(14-28)13-27-9-6-18(7-10-27)26-21(31)29-12-8-20(30)15-29/h1-5,11,14,18,20,30H,6-10,12-13,15H2,(H,26,31)/t20-/m1/s1 | Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 138 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Displacement of [125I]MCH from human MCH1 receptor expressed in HEK293 cells |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Melanin-concentrating hormone receptor 1
(Homo sapiens (Human)) | BDBM50297651
((R)-1-(2-hydroxy-1-phenylethyl)-3-(1-((1-(4-(trifl...)Show SMILES OC[C@H](NC(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1)c1ccccc1 |r| Show InChI InChI=1S/C26H29F3N4O2/c27-26(28,29)21-6-8-23(9-7-21)33-15-10-19(17-33)16-32-13-11-22(12-14-32)30-25(35)31-24(18-34)20-4-2-1-3-5-20/h1-10,15,17,22,24,34H,11-14,16,18H2,(H2,30,31,35)/t24-/m0/s1 | Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 152 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Displacement of [125I]MCH from human MCH1 receptor expressed in HEK293 cells |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Melanin-concentrating hormone receptor 1
(Homo sapiens (Human)) | BDBM50297649
(5-chloro-6-oxo-N-(1-((1-(4-(trifluoromethyl)phenyl...)Show SMILES FC(F)(F)c1ccc(cc1)-n1ccc(CN2CCC(CC2)NC(=O)c2c[nH]c(=O)c(Cl)c2)c1 Show InChI InChI=1S/C23H22ClF3N4O2/c24-20-11-16(12-28-22(20)33)21(32)29-18-6-8-30(9-7-18)13-15-5-10-31(14-15)19-3-1-17(2-4-19)23(25,26)27/h1-5,10-12,14,18H,6-9,13H2,(H,28,33)(H,29,32) | Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 196 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Displacement of [125I]MCH from human MCH1 receptor expressed in HEK293 cells |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Melanin-concentrating hormone receptor 1
(Homo sapiens (Human)) | BDBM50297641
(3-(1,4-oxazepan-4-yl)-N-(1-((1-(4-(trifluoromethyl...)Show SMILES FC(F)(F)c1ccc(cc1)-n1ccc(CN2CCC(CC2)NC(=O)N2CC(C2)N2CCCOCC2)c1 Show InChI InChI=1S/C26H34F3N5O2/c27-26(28,29)21-2-4-23(5-3-21)33-12-6-20(17-33)16-31-10-7-22(8-11-31)30-25(35)34-18-24(19-34)32-9-1-14-36-15-13-32/h2-6,12,17,22,24H,1,7-11,13-16,18-19H2,(H,30,35) | Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 236 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Displacement of [125I]MCH from human MCH1 receptor expressed in HEK293 cells |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Melanin-concentrating hormone receptor 1
(Homo sapiens (Human)) | BDBM50297622
(1-(1-(1H-imidazol-1-yl)propan-2-yl)-3-(1-((1-(4-(t...)Show SMILES CC(Cn1ccnc1)NC(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1 Show InChI InChI=1S/C24H29F3N6O/c1-18(14-32-13-9-28-17-32)29-23(34)30-21-7-10-31(11-8-21)15-19-6-12-33(16-19)22-4-2-20(3-5-22)24(25,26)27/h2-6,9,12-13,16-18,21H,7-8,10-11,14-15H2,1H3,(H2,29,30,34) | Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 308 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Displacement of [125I]MCH from human MCH1 receptor expressed in HEK293 cells |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50297622
(1-(1-(1H-imidazol-1-yl)propan-2-yl)-3-(1-((1-(4-(t...)Show SMILES CC(Cn1ccnc1)NC(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1 Show InChI InChI=1S/C24H29F3N6O/c1-18(14-32-13-9-28-17-32)29-23(34)30-21-7-10-31(11-8-21)15-19-6-12-33(16-19)22-4-2-20(3-5-22)24(25,26)27/h2-6,9,12-13,16-18,21H,7-8,10-11,14-15H2,1H3,(H2,29,30,34) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 320 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human recombinant CYP3A4 after 45 mins |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Melanin-concentrating hormone receptor 1
(Homo sapiens (Human)) | BDBM50297623
(3-phenyl-3-(3-(1-((1-(4-(trifluoromethyl)phenyl)-1...)Show SMILES OC(=O)CC(NC(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1)c1ccccc1 Show InChI InChI=1S/C27H29F3N4O3/c28-27(29,30)21-6-8-23(9-7-21)34-15-10-19(18-34)17-33-13-11-22(12-14-33)31-26(37)32-24(16-25(35)36)20-4-2-1-3-5-20/h1-10,15,18,22,24H,11-14,16-17H2,(H,35,36)(H2,31,32,37) | Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 412 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Displacement of [125I]MCH from human MCH1 receptor expressed in HEK293 cells |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50245454
(2-(3-chlorophenoxy)-N-(1-((1-(4-(trifluoromethyl)p...)Show SMILES FC(F)(F)c1ccc(cc1)-n1ccc(CN2CCC(CC2)NC(=O)COc2cccc(Cl)c2)c1 Show InChI InChI=1S/C25H25ClF3N3O2/c26-20-2-1-3-23(14-20)34-17-24(33)30-21-9-11-31(12-10-21)15-18-8-13-32(16-18)22-6-4-19(5-7-22)25(27,28)29/h1-8,13-14,16,21H,9-12,15,17H2,(H,30,33) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 560 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by patch-clamp assay |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50297620
(1-(1-phenyl-2-(1H-1,2,4-triazol-1-yl)ethyl)-3-(1-(...)Show SMILES FC(F)(F)c1ccc(cc1)-n1ccc(CN2CCC(CC2)NC(=O)NC(Cn2cncn2)c2ccccc2)c1 Show InChI InChI=1S/C28H30F3N7O/c29-28(30,31)23-6-8-25(9-7-23)37-15-10-21(17-37)16-36-13-11-24(12-14-36)34-27(39)35-26(18-38-20-32-19-33-38)22-4-2-1-3-5-22/h1-10,15,17,19-20,24,26H,11-14,16,18H2,(H2,34,35,39) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 570 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human recombinant CYP3A4 after 45 mins |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Melanin-concentrating hormone receptor 1
(Homo sapiens (Human)) | BDBM50297652
(4-fluoro-N-(1-((1-(4-(trifluoromethyl)phenyl)-1H-p...)Show SMILES Fc1ccc(cc1)S(=O)(=O)NC(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1 Show InChI InChI=1S/C24H24F4N4O3S/c25-19-3-7-22(8-4-19)36(34,35)30-23(33)29-20-10-12-31(13-11-20)15-17-9-14-32(16-17)21-5-1-18(2-6-21)24(26,27)28/h1-9,14,16,20H,10-13,15H2,(H2,29,30,33) | Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 617 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Displacement of [125I]MCH from human MCH1 receptor expressed in HEK293 cells |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50297625
(1-(2-(3,5-dimethyl-1H-pyrazol-1-yl)-1-phenylethyl)...)Show SMILES Cc1cc(C)n(CC(NC(=O)NC2CCN(Cc3ccn(c3)-c3ccc(cc3)C(F)(F)F)CC2)c2ccccc2)n1 Show InChI InChI=1S/C31H35F3N6O/c1-22-18-23(2)40(37-22)21-29(25-6-4-3-5-7-25)36-30(41)35-27-13-15-38(16-14-27)19-24-12-17-39(20-24)28-10-8-26(9-11-28)31(32,33)34/h3-12,17-18,20,27,29H,13-16,19,21H2,1-2H3,(H2,35,36,41) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 790 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human recombinant CYP3A4 after 45 mins |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50297636
(1-(3-fluorobenzyl)-3-(1-((1-(4-(trifluoromethyl)ph...)Show SMILES Fc1cccc(CNC(=O)NC2CCN(Cc3ccn(c3)-c3ccc(cc3)C(F)(F)F)CC2)c1 Show InChI InChI=1S/C25H26F4N4O/c26-21-3-1-2-18(14-21)15-30-24(34)31-22-9-11-32(12-10-22)16-19-8-13-33(17-19)23-6-4-20(5-7-23)25(27,28)29/h1-8,13-14,17,22H,9-12,15-16H2,(H2,30,31,34) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by patch-clamp assay |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50297624
(1-phenyl-N-(1-((1-(4-(trifluoromethyl)phenyl)-1H-p...)Show SMILES FC(F)(F)c1ccc(cc1)-n1ccc(CN2CCC(CC2)NC(=O)N2CCn3cccc3C2c2ccccc2)c1 Show InChI InChI=1S/C31H32F3N5O/c32-31(33,34)25-8-10-27(11-9-25)38-18-12-23(22-38)21-36-16-13-26(14-17-36)35-30(40)39-20-19-37-15-4-7-28(37)29(39)24-5-2-1-3-6-24/h1-12,15,18,22,26,29H,13-14,16-17,19-21H2,(H,35,40) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 1.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by patch-clamp assay |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50297631
(2-(pyridin-3-ylmethyl)-N-(1-((1-(4-(trifluoromethy...)Show SMILES FC(F)(F)c1ccc(cc1)-n1ccc(CN2CCC(CC2)NC(=O)N2CCCC2Cc2cccnc2)c1 Show InChI InChI=1S/C28H32F3N5O/c29-28(30,31)23-5-7-25(8-6-23)35-16-9-22(20-35)19-34-14-10-24(11-15-34)33-27(37)36-13-2-4-26(36)17-21-3-1-12-32-18-21/h1,3,5-9,12,16,18,20,24,26H,2,4,10-11,13-15,17,19H2,(H,33,37) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.73E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by patch-clamp assay |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50297626
(2-(4-fluorophenyl)-N-(1-((1-(4-(trifluoromethyl)ph...)Show SMILES Fc1ccc(cc1)C1CCCN1C(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1 Show InChI InChI=1S/C28H30F4N4O/c29-23-7-3-21(4-8-23)26-2-1-14-36(26)27(37)33-24-12-15-34(16-13-24)18-20-11-17-35(19-20)25-9-5-22(6-10-25)28(30,31)32/h3-11,17,19,24,26H,1-2,12-16,18H2,(H,33,37) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.81E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by patch-clamp assay |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50297619
(1-(2-(2-methyl-1H-imidazol-1-yl)-1-phenylethyl)-3-...)Show SMILES Cc1nccn1CC(NC(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1)c1ccccc1 Show InChI InChI=1S/C30H33F3N6O/c1-22-34-14-18-38(22)21-28(24-5-3-2-4-6-24)36-29(40)35-26-12-15-37(16-13-26)19-23-11-17-39(20-23)27-9-7-25(8-10-27)30(31,32)33/h2-11,14,17-18,20,26,28H,12-13,15-16,19,21H2,1H3,(H2,35,36,40) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 2.02E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human recombinant CYP3A4 after 45 mins |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50297639
(3-(4-methoxyphenoxy)-N-(1-((1-(4-(trifluoromethyl)...)Show SMILES COc1ccc(OC2CN(C2)C(=O)NC2CCN(Cc3ccn(c3)-c3ccc(cc3)C(F)(F)F)CC2)cc1 Show InChI InChI=1S/C28H31F3N4O3/c1-37-24-6-8-25(9-7-24)38-26-18-35(19-26)27(36)32-22-11-13-33(14-12-22)16-20-10-15-34(17-20)23-4-2-21(3-5-23)28(29,30)31/h2-10,15,17,22,26H,11-14,16,18-19H2,1H3,(H,32,36) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 2.03E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by patch-clamp assay |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50297640
(1-((1-hydroxycyclohexyl)methyl)-1-methyl-3-(1-((1-...)Show SMILES CN(CC1(O)CCCCC1)C(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1 Show InChI InChI=1S/C26H35F3N4O2/c1-31(19-25(35)12-3-2-4-13-25)24(34)30-22-10-14-32(15-11-22)17-20-9-16-33(18-20)23-7-5-21(6-8-23)26(27,28)29/h5-9,16,18,22,35H,2-4,10-15,17,19H2,1H3,(H,30,34) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 2.16E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by patch-clamp assay |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50297624
(1-phenyl-N-(1-((1-(4-(trifluoromethyl)phenyl)-1H-p...)Show SMILES FC(F)(F)c1ccc(cc1)-n1ccc(CN2CCC(CC2)NC(=O)N2CCn3cccc3C2c2ccccc2)c1 Show InChI InChI=1S/C31H32F3N5O/c32-31(33,34)25-8-10-27(11-9-25)38-18-12-23(22-38)21-36-16-13-26(14-17-36)35-30(40)39-20-19-37-15-4-7-28(37)29(39)24-5-2-1-3-6-24/h1-12,15,18,22,26,29H,13-14,16-17,19-21H2,(H,35,40) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 2.49E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human recombinant CYP3A4 after 45 mins |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50297625
(1-(2-(3,5-dimethyl-1H-pyrazol-1-yl)-1-phenylethyl)...)Show SMILES Cc1cc(C)n(CC(NC(=O)NC2CCN(Cc3ccn(c3)-c3ccc(cc3)C(F)(F)F)CC2)c2ccccc2)n1 Show InChI InChI=1S/C31H35F3N6O/c1-22-18-23(2)40(37-22)21-29(25-6-4-3-5-7-25)36-30(41)35-27-13-15-38(16-14-27)19-24-12-17-39(20-24)28-10-8-26(9-11-28)31(32,33)34/h3-12,17-18,20,27,29H,13-16,19,21H2,1-2H3,(H2,35,36,41) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 2.84E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by patch-clamp assay |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50297641
(3-(1,4-oxazepan-4-yl)-N-(1-((1-(4-(trifluoromethyl...)Show SMILES FC(F)(F)c1ccc(cc1)-n1ccc(CN2CCC(CC2)NC(=O)N2CC(C2)N2CCCOCC2)c1 Show InChI InChI=1S/C26H34F3N5O2/c27-26(28,29)21-2-4-23(5-3-21)33-12-6-20(17-33)16-31-10-7-22(8-11-31)30-25(35)34-18-24(19-34)32-9-1-14-36-15-13-32/h2-6,12,17,22,24H,1,7-11,13-16,18-19H2,(H,30,35) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by patch-clamp assay |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50297629
(2-(pyridin-3-yl)-N-(1-((1-(4-(trifluoromethyl)phen...)Show SMILES FC(F)(F)c1ccc(cc1)-n1ccc(CN2CCC(CC2)NC(=O)N2CCCC2c2cccnc2)c1 Show InChI InChI=1S/C27H30F3N5O/c28-27(29,30)22-5-7-24(8-6-22)34-16-9-20(19-34)18-33-14-10-23(11-15-33)32-26(36)35-13-2-4-25(35)21-3-1-12-31-17-21/h1,3,5-9,12,16-17,19,23,25H,2,4,10-11,13-15,18H2,(H,32,36) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 3.08E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by patch-clamp assay |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50297637
(2-(2-hydroxyethyl)-N-(1-((1-(4-(trifluoromethyl)ph...)Show SMILES OCCC1CCCCN1C(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1 Show InChI InChI=1S/C25H33F3N4O2/c26-25(27,28)20-4-6-22(7-5-20)31-15-8-19(18-31)17-30-13-9-21(10-14-30)29-24(34)32-12-2-1-3-23(32)11-16-33/h4-8,15,18,21,23,33H,1-3,9-14,16-17H2,(H,29,34) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 3.08E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by patch-clamp assay |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50297627
(1-(1-phenyl-2-(pyrazin-2-yl)ethyl)-3-(1-((1-(4-(tr...)Show SMILES FC(F)(F)c1ccc(cc1)-n1ccc(CN2CCC(CC2)NC(=O)NC(Cc2cnccn2)c2ccccc2)c1 Show InChI InChI=1S/C30H31F3N6O/c31-30(32,33)24-6-8-27(9-7-24)39-17-10-22(21-39)20-38-15-11-25(12-16-38)36-29(40)37-28(23-4-2-1-3-5-23)18-26-19-34-13-14-35-26/h1-10,13-14,17,19,21,25,28H,11-12,15-16,18,20H2,(H2,36,37,40) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 3.22E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human recombinant CYP3A4 after 45 mins |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50297642
(1-(4-chloro-2-(hydroxymethyl)phenyl)-3-(1-((1-(4-(...)Show SMILES OCc1cc(Cl)ccc1NC(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1 Show InChI InChI=1S/C25H26ClF3N4O2/c26-20-3-6-23(18(13-20)16-34)31-24(35)30-21-8-10-32(11-9-21)14-17-7-12-33(15-17)22-4-1-19(2-5-22)25(27,28)29/h1-7,12-13,15,21,34H,8-11,14,16H2,(H2,30,31,35) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 3.33E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by patch-clamp assay |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50297643
(CHEMBL550535 | N-(1-((1-(4-(trifluoromethyl)phenyl...)Show SMILES FC(F)(F)C1CCN(CC1)C1CN(C1)C(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1 Show InChI InChI=1S/C27H33F6N5O/c28-26(29,30)20-1-3-23(4-2-20)37-12-5-19(16-37)15-35-10-8-22(9-11-35)34-25(39)38-17-24(18-38)36-13-6-21(7-14-36)27(31,32)33/h1-5,12,16,21-22,24H,6-11,13-15,17-18H2,(H,34,39) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 3.87E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by patch-clamp assay |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50297644
(1-(((1R,2R)-2-hydroxycyclohexyl)methyl)-3-(1-((1-(...)Show SMILES O[C@@H]1CCCC[C@@H]1CNC(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1 |r| Show InChI InChI=1S/C25H33F3N4O2/c26-25(27,28)20-5-7-22(8-6-20)32-14-9-18(17-32)16-31-12-10-21(11-13-31)30-24(34)29-15-19-3-1-2-4-23(19)33/h5-9,14,17,19,21,23,33H,1-4,10-13,15-16H2,(H2,29,30,34)/t19-,23-/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 3.96E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by patch-clamp assay |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50297628
(1-(1-phenyl-2-(1H-pyrazol-1-yl)ethyl)-3-(1-((1-(4-...)Show SMILES FC(F)(F)c1ccc(cc1)-n1ccc(CN2CCC(CC2)NC(=O)NC(Cn2cccn2)c2ccccc2)c1 Show InChI InChI=1S/C29H31F3N6O/c30-29(31,32)24-7-9-26(10-8-24)37-18-11-22(20-37)19-36-16-12-25(13-17-36)34-28(39)35-27(21-38-15-4-14-33-38)23-5-2-1-3-6-23/h1-11,14-15,18,20,25,27H,12-13,16-17,19,21H2,(H2,34,35,39) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 4.04E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by patch-clamp assay |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50297635
(4-(2-hydroxyphenyl)-N-(1-((1-(4-(trifluoromethyl)p...)Show SMILES Oc1ccccc1C1CCN(CC1)C(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1 Show InChI InChI=1S/C29H33F3N4O2/c30-29(31,32)23-5-7-25(8-6-23)36-16-9-21(20-36)19-34-14-12-24(13-15-34)33-28(38)35-17-10-22(11-18-35)26-3-1-2-4-27(26)37/h1-9,16,20,22,24,37H,10-15,17-19H2,(H,33,38) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 4.12E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by patch-clamp assay |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50297628
(1-(1-phenyl-2-(1H-pyrazol-1-yl)ethyl)-3-(1-((1-(4-...)Show SMILES FC(F)(F)c1ccc(cc1)-n1ccc(CN2CCC(CC2)NC(=O)NC(Cn2cccn2)c2ccccc2)c1 Show InChI InChI=1S/C29H31F3N6O/c30-29(31,32)24-7-9-26(10-8-24)37-18-11-22(20-37)19-36-16-12-25(13-17-36)34-28(39)35-27(21-38-15-4-14-33-38)23-5-2-1-3-6-23/h1-11,14-15,18,20,25,27H,12-13,16-17,19,21H2,(H2,34,35,39) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 4.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human recombinant CYP3A4 after 45 mins |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50297633
(4-methyl-2-phenyl-N-(1-((1-(4-(trifluoromethyl)phe...)Show SMILES CN1CCN(C(C1)c1ccccc1)C(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1 Show InChI InChI=1S/C29H34F3N5O/c1-34-17-18-37(27(21-34)23-5-3-2-4-6-23)28(38)33-25-12-14-35(15-13-25)19-22-11-16-36(20-22)26-9-7-24(8-10-26)29(30,31)32/h2-11,16,20,25,27H,12-15,17-19,21H2,1H3,(H,33,38) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 4.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by patch-clamp assay |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50297630
(3-(hydroxymethyl)-N-(1-((1-(4-(trifluoromethyl)phe...)Show SMILES OCC1CCCN(C1)C(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1 Show InChI InChI=1S/C24H31F3N4O2/c25-24(26,27)20-3-5-22(6-4-20)30-13-7-18(15-30)14-29-11-8-21(9-12-29)28-23(33)31-10-1-2-19(16-31)17-32/h3-7,13,15,19,21,32H,1-2,8-12,14,16-17H2,(H,28,33) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 4.89E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by patch-clamp assay |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50297627
(1-(1-phenyl-2-(pyrazin-2-yl)ethyl)-3-(1-((1-(4-(tr...)Show SMILES FC(F)(F)c1ccc(cc1)-n1ccc(CN2CCC(CC2)NC(=O)NC(Cc2cnccn2)c2ccccc2)c1 Show InChI InChI=1S/C30H31F3N6O/c31-30(32,33)24-6-8-27(9-7-24)39-17-10-22(21-39)20-38-15-11-25(12-16-38)36-29(40)37-28(23-4-2-1-3-5-23)18-26-19-34-13-14-35-26/h1-10,13-14,17,19,21,25,28H,11-12,15-16,18,20H2,(H2,36,37,40) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 5.34E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by patch-clamp assay |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50297645
(1-(2-morpholino-1-phenylethyl)-3-(1-((1-(4-(triflu...)Show SMILES FC(F)(F)c1ccc(cc1)-n1ccc(CN2CCC(CC2)NC(=O)NC(CN2CCOCC2)c2ccccc2)c1 Show InChI InChI=1S/C30H36F3N5O2/c31-30(32,33)25-6-8-27(9-7-25)38-15-10-23(21-38)20-36-13-11-26(12-14-36)34-29(39)35-28(24-4-2-1-3-5-24)22-37-16-18-40-19-17-37/h1-10,15,21,26,28H,11-14,16-20,22H2,(H2,34,35,39) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 6.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by patch-clamp assay |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50297646
(1-(((1S,2R)-2-hydroxycyclohexyl)methyl)-3-(1-((1-(...)Show SMILES O[C@@H]1CCCC[C@H]1CNC(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1 |r| Show InChI InChI=1S/C25H33F3N4O2/c26-25(27,28)20-5-7-22(8-6-20)32-14-9-18(17-32)16-31-12-10-21(11-13-31)30-24(34)29-15-19-3-1-2-4-23(19)33/h5-9,14,17,19,21,23,33H,1-4,10-13,15-16H2,(H2,29,30,34)/t19-,23+/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 7.33E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by patch-clamp assay |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50297647
(4-benzyl-4-hydroxy-N-(1-((1-(4-(trifluoromethyl)ph...)Show SMILES OC1(Cc2ccccc2)CCN(CC1)C(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1 Show InChI InChI=1S/C30H35F3N4O2/c31-30(32,33)25-6-8-27(9-7-25)37-17-10-24(22-37)21-35-15-11-26(12-16-35)34-28(38)36-18-13-29(39,14-19-36)20-23-4-2-1-3-5-23/h1-10,17,22,26,39H,11-16,18-21H2,(H,34,38) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 7.93E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by patch-clamp assay |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50297638
(3-(pyrrolidine-1-carbonyl)-N-(1-((1-(4-(trifluorom...)Show SMILES FC(F)(F)c1ccc(cc1)-n1ccc(CN2CCC(CC2)NC(=O)N2CCCC(C2)C(=O)N2CCCC2)c1 Show InChI InChI=1S/C28H36F3N5O2/c29-28(30,31)23-5-7-25(8-6-23)35-17-9-21(19-35)18-33-15-10-24(11-16-33)32-27(38)36-14-3-4-22(20-36)26(37)34-12-1-2-13-34/h5-9,17,19,22,24H,1-4,10-16,18,20H2,(H,32,38) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.17E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by patch-clamp assay |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50297632
(1-((1H-imidazol-2-yl)(phenyl)methyl)-3-(1-((1-(4-(...)Show SMILES FC(F)(F)c1ccc(cc1)-n1ccc(CN2CCC(CC2)NC(=O)NC(c2ncc[nH]2)c2ccccc2)c1 Show InChI InChI=1S/C28H29F3N6O/c29-28(30,31)22-6-8-24(9-7-22)37-17-10-20(19-37)18-36-15-11-23(12-16-36)34-27(38)35-25(26-32-13-14-33-26)21-4-2-1-3-5-21/h1-10,13-14,17,19,23,25H,11-12,15-16,18H2,(H,32,33)(H2,34,35,38) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.27E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by patch-clamp assay |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50297632
(1-((1H-imidazol-2-yl)(phenyl)methyl)-3-(1-((1-(4-(...)Show SMILES FC(F)(F)c1ccc(cc1)-n1ccc(CN2CCC(CC2)NC(=O)NC(c2ncc[nH]2)c2ccccc2)c1 Show InChI InChI=1S/C28H29F3N6O/c29-28(30,31)22-6-8-24(9-7-22)37-17-10-20(19-37)18-36-15-11-23(12-16-36)34-27(38)35-25(26-32-13-14-33-26)21-4-2-1-3-5-21/h1-10,13-14,17,19,23,25H,11-12,15-16,18H2,(H,32,33)(H2,34,35,38) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.34E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human recombinant CYP3A4 after 45 mins |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50297648
(1-((1H-benzo[d]imidazol-2-yl)methyl)-3-(1-((1-(4-(...)Show SMILES FC(F)(F)c1ccc(cc1)-n1ccc(CN2CCC(CC2)NC(=O)NCc2nc3ccccc3[nH]2)c1 Show InChI InChI=1S/C26H27F3N6O/c27-26(28,29)19-5-7-21(8-6-19)35-14-9-18(17-35)16-34-12-10-20(11-13-34)31-25(36)30-15-24-32-22-3-1-2-4-23(22)33-24/h1-9,14,17,20H,10-13,15-16H2,(H,32,33)(H2,30,31,36) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.47E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by patch-clamp assay |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50297645
(1-(2-morpholino-1-phenylethyl)-3-(1-((1-(4-(triflu...)Show SMILES FC(F)(F)c1ccc(cc1)-n1ccc(CN2CCC(CC2)NC(=O)NC(CN2CCOCC2)c2ccccc2)c1 Show InChI InChI=1S/C30H36F3N5O2/c31-30(32,33)25-6-8-27(9-7-25)38-15-10-23(21-38)20-36-13-11-26(12-14-36)34-29(39)35-28(24-4-2-1-3-5-24)22-37-16-18-40-19-17-37/h1-10,15,21,26,28H,11-14,16-20,22H2,(H2,34,35,39) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.65E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human recombinant CYP3A4 after 45 mins |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50297649
(5-chloro-6-oxo-N-(1-((1-(4-(trifluoromethyl)phenyl...)Show SMILES FC(F)(F)c1ccc(cc1)-n1ccc(CN2CCC(CC2)NC(=O)c2c[nH]c(=O)c(Cl)c2)c1 Show InChI InChI=1S/C23H22ClF3N4O2/c24-20-11-16(12-28-22(20)33)21(32)29-18-6-8-30(9-7-18)13-15-5-10-31(14-15)19-3-1-17(2-4-19)23(25,26)27/h1-5,10-12,14,18H,6-9,13H2,(H,28,33)(H,29,32) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 1.96E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by patch-clamp assay |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50297634
((S)-1-(2-hydroxy-1-phenylethyl)-3-(1-((1-(4-(trifl...)Show SMILES OC[C@@H](NC(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1)c1ccccc1 |r| Show InChI InChI=1S/C26H29F3N4O2/c27-26(28,29)21-6-8-23(9-7-21)33-15-10-19(17-33)16-32-13-11-22(12-14-32)30-25(35)31-24(18-34)20-4-2-1-3-5-20/h1-10,15,17,22,24,34H,11-14,16,18H2,(H2,30,31,35)/t24-/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 2.06E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human recombinant CYP3A4 after 45 mins |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50297650
(1-(1-(1H-imidazol-1-yl)-3-methylbutan-2-yl)-3-(1-(...)Show SMILES CC(C)C(Cn1ccnc1)NC(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1 Show InChI InChI=1S/C26H33F3N6O/c1-19(2)24(17-34-14-10-30-18-34)32-25(36)31-22-8-11-33(12-9-22)15-20-7-13-35(16-20)23-5-3-21(4-6-23)26(27,28)29/h3-7,10,13-14,16,18-19,22,24H,8-9,11-12,15,17H2,1-2H3,(H2,31,32,36) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 2.09E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by patch-clamp assay |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50297634
((S)-1-(2-hydroxy-1-phenylethyl)-3-(1-((1-(4-(trifl...)Show SMILES OC[C@@H](NC(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1)c1ccccc1 |r| Show InChI InChI=1S/C26H29F3N4O2/c27-26(28,29)21-6-8-23(9-7-21)33-15-10-19(17-33)16-32-13-11-22(12-14-32)30-25(35)31-24(18-34)20-4-2-1-3-5-20/h1-10,15,17,22,24,34H,11-14,16,18H2,(H2,30,31,35)/t24-/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 2.39E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by patch-clamp assay |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50297651
((R)-1-(2-hydroxy-1-phenylethyl)-3-(1-((1-(4-(trifl...)Show SMILES OC[C@H](NC(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1)c1ccccc1 |r| Show InChI InChI=1S/C26H29F3N4O2/c27-26(28,29)21-6-8-23(9-7-21)33-15-10-19(17-33)16-32-13-11-22(12-14-32)30-25(35)31-24(18-34)20-4-2-1-3-5-20/h1-10,15,17,22,24,34H,11-14,16,18H2,(H2,30,31,35)/t24-/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 2.58E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by patch-clamp assay |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50297621
(1-(2-(1H-imidazol-1-yl)-1-phenylethyl)-3-(1-((1-(4...)Show SMILES FC(F)(F)c1ccc(cc1)-n1ccc(CN2CCC(CC2)NC(=O)NC(Cn2ccnc2)c2ccccc2)c1 Show InChI InChI=1S/C29H31F3N6O/c30-29(31,32)24-6-8-26(9-7-24)38-16-10-22(19-38)18-36-14-11-25(12-15-36)34-28(39)35-27(20-37-17-13-33-21-37)23-4-2-1-3-5-23/h1-10,13,16-17,19,21,25,27H,11-12,14-15,18,20H2,(H2,34,35,39) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | >3.16E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by patch-clamp assay |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50297618
(1-(3-Hydroxy-adamantan-1-yl)-3-{1-[1-(4-trifluorom...)Show SMILES OC12CC3CC(C1)CC(C3)(C2)NC(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1 |TLB:11:8:4:2.1.6,9:8:4.3.2:6,0:1:4:7.9.8,THB:9:3:6:7.8.10,10:8:4:2.1.6,10:1:4:7.9.8| Show InChI InChI=1S/C28H35F3N4O2/c29-28(30,31)22-1-3-24(4-2-22)35-10-5-19(17-35)16-34-8-6-23(7-9-34)32-25(36)33-26-12-20-11-21(13-26)15-27(37,14-20)18-26/h1-5,10,17,20-21,23,37H,6-9,11-16,18H2,(H2,32,33,36) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | >3.16E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by patch-clamp assay |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50297619
(1-(2-(2-methyl-1H-imidazol-1-yl)-1-phenylethyl)-3-...)Show SMILES Cc1nccn1CC(NC(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1)c1ccccc1 Show InChI InChI=1S/C30H33F3N6O/c1-22-34-14-18-38(22)21-28(24-5-3-2-4-6-24)36-29(40)35-26-12-15-37(16-13-26)19-23-11-17-39(20-23)27-9-7-25(8-10-27)30(31,32)33/h2-11,14,17-18,20,26,28H,12-13,15-16,19,21H2,1H3,(H2,35,36,40) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | >3.16E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by patch-clamp assay |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50297623
(3-phenyl-3-(3-(1-((1-(4-(trifluoromethyl)phenyl)-1...)Show SMILES OC(=O)CC(NC(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1)c1ccccc1 Show InChI InChI=1S/C27H29F3N4O3/c28-27(29,30)21-6-8-23(9-7-21)34-15-10-19(18-34)17-33-13-11-22(12-14-33)31-26(37)32-24(16-25(35)36)20-4-2-1-3-5-20/h1-10,15,18,22,24H,11-14,16-17H2,(H,35,36)(H2,31,32,37) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | >3.16E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by patch-clamp assay |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50297617
(1-((1-hydroxycyclohexyl)methyl)-3-(1-((1-(4-(trifl...)Show SMILES OC1(CNC(=O)NC2CCN(Cc3ccn(c3)-c3ccc(cc3)C(F)(F)F)CC2)CCCCC1 Show InChI InChI=1S/C25H33F3N4O2/c26-25(27,28)20-4-6-22(7-5-20)32-15-8-19(17-32)16-31-13-9-21(10-14-31)30-23(33)29-18-24(34)11-2-1-3-12-24/h4-8,15,17,21,34H,1-3,9-14,16,18H2,(H2,29,30,33) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | >3.16E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by patch-clamp assay |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50297622
(1-(1-(1H-imidazol-1-yl)propan-2-yl)-3-(1-((1-(4-(t...)Show SMILES CC(Cn1ccnc1)NC(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1 Show InChI InChI=1S/C24H29F3N6O/c1-18(14-32-13-9-28-17-32)29-23(34)30-21-7-10-31(11-8-21)15-19-6-12-33(16-19)22-4-2-20(3-5-22)24(25,26)27/h2-6,9,12-13,16-18,21H,7-8,10-11,14-15H2,1H3,(H2,29,30,34) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | >3.16E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by patch-clamp assay |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50297653
(3-(1,1-Dioxo-1lambda6-thiomorpholin-4-yl)-azetidin...)Show SMILES FC(F)(F)c1ccc(cc1)-n1ccc(CN2CCC(CC2)NC(=O)N2CC(C2)N2CCS(=O)(=O)CC2)c1 Show InChI InChI=1S/C25H32F3N5O3S/c26-25(27,28)20-1-3-22(4-2-20)32-10-5-19(16-32)15-30-8-6-21(7-9-30)29-24(34)33-17-23(18-33)31-11-13-37(35,36)14-12-31/h1-5,10,16,21,23H,6-9,11-15,17-18H2,(H,29,34) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | >3.16E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by patch-clamp assay |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50297654
(3-acetamido-N-(1-((1-(4-(trifluoromethyl)phenyl)-1...)Show SMILES CC(=O)NC1CCN(C1)C(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1 Show InChI InChI=1S/C24H30F3N5O2/c1-17(33)28-21-9-13-32(16-21)23(34)29-20-7-10-30(11-8-20)14-18-6-12-31(15-18)22-4-2-19(3-5-22)24(25,26)27/h2-6,12,15,20-21H,7-11,13-14,16H2,1H3,(H,28,33)(H,29,34) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | >3.16E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by patch-clamp assay |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50297620
(1-(1-phenyl-2-(1H-1,2,4-triazol-1-yl)ethyl)-3-(1-(...)Show SMILES FC(F)(F)c1ccc(cc1)-n1ccc(CN2CCC(CC2)NC(=O)NC(Cn2cncn2)c2ccccc2)c1 Show InChI InChI=1S/C28H30F3N7O/c29-28(30,31)23-6-8-25(9-7-23)37-15-10-21(17-37)16-36-13-11-24(12-14-36)34-27(39)35-26(18-38-20-32-19-33-38)22-4-2-1-3-5-22/h1-10,15,17,19-20,24,26H,11-14,16,18H2,(H2,34,35,39) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | >3.16E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by patch-clamp assay |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50297616
((S)-3-hydroxy-N-(1-((1-(4-(trifluoromethyl)phenyl)...)Show SMILES O[C@H]1CCN(C1)C(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1 |r| Show InChI InChI=1S/C22H27F3N4O2/c23-22(24,25)17-1-3-19(4-2-17)28-11-5-16(14-28)13-27-9-6-18(7-10-27)26-21(31)29-12-8-20(30)15-29/h1-5,11,14,18,20,30H,6-10,12-13,15H2,(H,26,31)/t20-/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | >3.16E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by patch-clamp assay |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50297652
(4-fluoro-N-(1-((1-(4-(trifluoromethyl)phenyl)-1H-p...)Show SMILES Fc1ccc(cc1)S(=O)(=O)NC(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1 Show InChI InChI=1S/C24H24F4N4O3S/c25-19-3-7-22(8-4-19)36(34,35)30-23(33)29-20-10-12-31(13-11-20)15-17-9-14-32(16-17)21-5-1-18(2-6-21)24(26,27)28/h1-9,14,16,20H,10-13,15H2,(H2,29,30,33) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | >3.16E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by patch-clamp assay |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50297615
((R)-3-hydroxy-N-(1-((1-(4-(trifluoromethyl)phenyl)...)Show SMILES O[C@@H]1CCN(C1)C(=O)NC1CCN(Cc2ccn(c2)-c2ccc(cc2)C(F)(F)F)CC1 |r| Show InChI InChI=1S/C22H27F3N4O2/c23-22(24,25)17-1-3-19(4-2-17)28-11-5-16(14-28)13-27-9-6-18(7-10-27)26-21(31)29-12-8-20(30)15-29/h1-5,11,14,18,20,30H,6-10,12-13,15H2,(H,26,31)/t20-/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | >3.16E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by patch-clamp assay |
Bioorg Med Chem Lett 19: 4274-9 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.066 BindingDB Entry DOI: 10.7270/Q24Q7V1J |
More data for this Ligand-Target Pair | |